Meet our board of directors
Lars Olof Sandén
Chairman of the board since 2021
Born: 1962
Education: Master’s degree from Chalmers, Gothenburg and ETH Zurich, Executive MBA Columbia, New York.
Other directorships: Micropos, ContextVision and Unisport OY.
Previous positions: Boston Consulting Group in Munich and Stockholm, Trade Commissioner and Regional Manager at Business Sweden, Vice President of Elekta, CEO of RISE (Research Institutes of Sweden), focusing on merging the Swedish research institutes into a national organization. Several M&A projects with subsequent integration work.
Current position: Partner at Transearch, an international executive search company.
Shareholding as of 28 February 2025: 116,840 shares and 98,390 options.
Education: Master’s degree from Chalmers, Gothenburg and ETH Zurich, Executive MBA Columbia, New York.
Other directorships: Micropos, ContextVision and Unisport OY.
Previous positions: Boston Consulting Group in Munich and Stockholm, Trade Commissioner and Regional Manager at Business Sweden, Vice President of Elekta, CEO of RISE (Research Institutes of Sweden), focusing on merging the Swedish research institutes into a national organization. Several M&A projects with subsequent integration work.
Current position: Partner at Transearch, an international executive search company.
Shareholding as of 28 February 2025: 116,840 shares and 98,390 options.
Knut Martin Henschen Ingvar
Member of the board since 2021
Born: 1955
Education: MD, Specialist in Clinical Neurophysiology, PhD
Other directorships: International Consortium for Health Outcome Measurement and ContextVision AB.
Previous positions: Dean of Research, Karolinska Institutet, 2009–2012. Managed Karolinska MR Research Centre for twentyfive years, published about 250 research papers and contributed to 15 books.
Current position: Barbro and Bernard Osher, Professor of Integrative Medicine at Karolinska Institutet. Current focus: formal description of clinical knowledge and quality in clinical care.
Shareholding as of 28 February 2025: 176,563 shares and 295,170 options.
Education: MD, Specialist in Clinical Neurophysiology, PhD
Other directorships: International Consortium for Health Outcome Measurement and ContextVision AB.
Previous positions: Dean of Research, Karolinska Institutet, 2009–2012. Managed Karolinska MR Research Centre for twentyfive years, published about 250 research papers and contributed to 15 books.
Current position: Barbro and Bernard Osher, Professor of Integrative Medicine at Karolinska Institutet. Current focus: formal description of clinical knowledge and quality in clinical care.
Shareholding as of 28 February 2025: 176,563 shares and 295,170 options.
Magne Jordanger
Member of the board since 2022
Born: 1953
Education: BA degree from IMD, Lausanne, Switzerland.
Other directorships: Monsun AS (Chair), Konsmo Fabrikker AS (Chair), Creditsafe Group S.A (Chair).
Shareholding as of 28 February 2025: 55,454,556 shares through Gallivant S.á.r.l. and Monsun AS.
Education: BA degree from IMD, Lausanne, Switzerland.
Other directorships: Monsun AS (Chair), Konsmo Fabrikker AS (Chair), Creditsafe Group S.A (Chair).
Shareholding as of 28 February 2025: 55,454,556 shares through Gallivant S.á.r.l. and Monsun AS.
Sven Christian Günther-Hanssen
Board member
Sven Günther-Hanssen (born 1954) is one of the founders of ContextVision, previous parent company of Inify Laboratories. He has served as CEO and chairman of the board of ContextVision and is currently a board member of ContextVision. Günther-Hanssen has acted as a venture capitalist and been involved in start-up companies in the medical, industrial, and financial sectors in the capacity of investor as well as board member. He holds a M.Sc. degree in Industrial Engineering from the Institute of Technology at Linköping University.